T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects

Journal of Autoimmunity

Volumn 12, Issue 4, 1999, Pages 259-267

  Semana, Gilbert ^a   Gausling, Rudolf ^a   Jackson, Richard A ^b   Hafler, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

Antigens; Autoimmunity; Diabetes; Epitopes; Human; Peptides; T lymphocytes

Indexed keywords

AUTOANTIGEN; EPITOPE; PROINSULIN;

ARTICLE; BETA CHAIN; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; CROSS REACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE SPECIFICITY;

EID: 0033023871     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0282     Document Type: Article

References (33)

1. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L., Hafler D.A. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 121:1995;1985-1996.
2. Vanderlugt C.J., Miller S.D. Epitope spreading. Curr. Opin. Immunol. 8:1996;831-836.
3. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:1992;155-157.
4. Bieganowska K.D., Ausubel L.J., Modabber Y., Slovik E., Messersmith W., Hafler D.A. Direct ex vivo analysis of activated, fas-sensitive autoreactive T cells in human autoimmune disease. J. Exp. Med. 9:1997;1585-1594.
5. Bach J.F. IDDM as an autoimmune disease. Endocr. Rev. 15:1994;516-542.
6. Roep B.O. Perspectives in diabetes: T cell responses to autoantigens in IDDM. The search for the holy grail. Diabetes. 45:1996;1147-1146.
7. Katz J.D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Sciences. 268:1995;1185-1188.
8. Harrison L.C. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol. Today. 13:1992;348-352.
9. Christie M.R. Islet cell autoantigens in type 1 diabetes. Eur. J. Clin. Invest. 26:1996;827-838.
10. Roep B.O., Kallan A.A., Duinkerken G., Arden S.D., Hutton J.C., Bruining G.J., Vries R.R.P. T-cell reactivity to β-cell membrane antigens associated with β-cell destruction in IDDM. Diabetes. 44:1995;278-283.
11. Brooks-Worrell B., Starkebaum G.A., Greenbaum C., Palmer J.P. Peripheral blood monoclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J. Immunol. 157:1996;5668-5674.
12. Durinovic-Bello I., Hummel M., Ziegler A.G. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes. 45:1996;795-800.
13. Kauffmann J.E., Irminger J.C., Mungall J., Halban P.A. Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3. Diabetes. 46:1997;978-982.
14. Harrison L.C., Chu S.X., Deaizpurua H.J., Graham M., Honeyman M.C., Colman P.G. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J. Clin. Invest. 89:1992;1161-1165.
15. Haskins K., Wegmann D. Diabetogenic T-cell clones. Diabetes. 45:1996;1299-1305.
16. Kuglin B., Gries F.A., Kolb H. Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes. 37:1988;130-132.
17. Raju R., Munn S.R., David C.S. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA-DQ8 and DQ6 transgenic mice. Hum. Immunol. 58:1997;21-29.
18. French M.B., Allison J., Cram D.S., Thomas H.E., Dempsey-Collier M., Silva A., Georgiou H.M., Kay T.W., Harrison L.C., Lew A.M. Transgenic expression of mouse proinsulin II prevents diabetes in non-obese diabetic mice. Diabetes. 46:1997;34-39.
19. Griffin A.C., Zhao W., Wegmann K.W., Hickey W.L. Experimental autoimmune insulitis induction by T lymphocytes specific for a peptide of proinsulin. Am. J. Pathol. 147:1995;845-857.
20. Ota K., Matsui M., Milford E.L., Mackin G.S., Weiner H.L., Hafler D.A. T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis. Nature. 346:1990;183-187.
21. Maugendre D., Alizadeh M., Gauthier A., Guilhem I., Pouillaud C., Genetet B., Allannic H., Semana G. Genetic heterogeneity between type 1a and type 1b insulin-dependent diabetes mellitus: HLA class II and TAP gene analysis. Tissue Antigens. 48:1996;540-548.
22. Markovic-Plese S., Fukaura H., Zhang J., Al-Sabbagh A., Southwood S., Sette A., Kuchroo V., Hafler D.A. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155:1995;982-992.
23. Naquet P., Ellis J., Tibensky D., Kenshole A., Singh B., Hodges R., Delovitch T.L. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J. Immunol. 140:1998;2569-2578.
24. Keller R.J. Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus. J. Autoimmun. 3:1990;321-327.
25. Schloot N.C., Roep B.O., Wegmann D., Yu L., Chase H.P., Wang T., Eisenbarth G.S. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia. 40:1997;564-572.
26. Akkaraju S., Ho W.Y., Leong D., Canaan K., Davis M.M., Goodnow C.C. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity. 2:1997;255-271.
27. 1. J. Immunol. 159:1997;2502-2512.
28. Sloan-Lancaster J., Allen P.M. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1996;1-2729.
29. Rudy G., Stone N., Harrison L.C., Colman P.G., McNair P., Brusic V., French M.B., Honeyman M.C., Tait B., Lew A.M. Similar peptides from twoβ cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med. 1:1995;625-633.
30. Daniel D., Gill R.G., Schloot N., Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1995;1056-1062.
31. Congia M., Patel S., Cope A.P., De Virgiliis S., Sonderstrup G. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc. Natl. Acad. Sci. USA. 95:1998;3833-3838.
32. Harrison L.C., Dempsey-Collier M., Kramer D.R., Takahashi K. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184:1996;2167-2174.
33. Zhang Z.J., Davidson L., Eisenbarth G., Weiner H.L. Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA. 88:1991;10252-10256.